Lipid abnormalities induced by novel antipsychotic drugs

Drug Safety

Volumn 24, Issue 13, 2001, Pages 1017-1018

  Mantel Teeuwisse, A K ^a   Klungel, O H ^a   De Boer, A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

AGRANULOCYTOSIS; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LETTER; OBESITY; PRIORITY JOURNAL; PSYCHOSIS; SEDATION; SEIZURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIPSYCHOTIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM;

EID: 85047700190     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124130-00008     Document Type: Letter

References (1)

1. 1. JH Barth SP Macdonald-Hull J Mark 1993 Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests Br J Dermatol 129 704 7 8286255 10.1111/j.1365-2133.1993.tb03336.x 1:STN:280:DyaK2c7hsVCjsg%3D%3D Barth JH, Macdonald-Hull SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129: 704–7